Your browser doesn't support javascript.
loading
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker, Jessalyn M; Haider, Marie-Therese; DeCristo, Molly J; Allocca, Gloria; Brown, Nicola J; Silver, Daniel P; Holen, Ingunn; McAllister, Sandra S.
Affiliation
  • Ubellacker JM; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
  • Haider MT; Hematology Division, Brigham & Women's Hospital, Boston, MA, 02115, USA.
  • DeCristo MJ; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
  • Allocca G; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
  • Brown NJ; Hematology Division, Brigham & Women's Hospital, Boston, MA, 02115, USA.
  • Silver DP; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
  • Holen I; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
  • McAllister SS; Departments of Medical Oncology and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Breast Cancer Res ; 19(1): 23, 2017 03 06.
Article in En | MEDLINE | ID: mdl-28264701

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bone Marrow Cells / Diphosphonates / Bone Density Conservation Agents / Hematopoiesis / Imidazoles Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Breast Cancer Res Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bone Marrow Cells / Diphosphonates / Bone Density Conservation Agents / Hematopoiesis / Imidazoles Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Breast Cancer Res Year: 2017 Document type: Article